New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
16. April 2024 09:15 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Prenatal Diagnosis has published a...
MTBC’s Data Science Team Presents at the 2017 Neural Information Processing Systems Conference
13. Dezember 2017 09:00 ET
|
MTBC
SOMERSET, N.J, Dec. 13, 2017 (GLOBE NEWSWIRE) -- MTBC (NASDAQ:MTBC) (NASDAQ: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, presented its state-of-the-art...
Wave Computing to Exhibit its Dataflow Technology for Deep Learning at NIPS
28. November 2017 08:30 ET
|
Wave Computing
CAMPBELL, Calif., Nov. 28, 2017 (GLOBE NEWSWIRE) -- Wave Computing™, the Silicon Valley start-up that is revolutionizing artificial intelligence and deep learning with its dataflow-based solutions,...
CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
10. November 2017 16:15 ET
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results
03. August 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
01. März 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
22. Februar 2017 16:05 ET
|
CombiMatrix Corporation
Achieves record quarterly reproductive health revenues and test volume, across-the-board increases in average revenue per test, expanded gross margin, significantly narrowed operating loss and record...
CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017
15. Februar 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference
08. Februar 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
20. Januar 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 20, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...